Replies to post #479980 on Anavex Life Sciences Corp (AVXL)

[Doc328]

Most of their communications raise more questions than they answer. Hard to spin "Additionally, the comprehensive data from the blarcamesine Alzheimer’s disease program represents a solid foundation for the subsequent strategy of our Phase III and IV development plan." positively but its ambiguous enough that it could be neutral. Missling will need to clarify this precisely later this week --- for now I will stick with 3-4% possibility of approval without an additional trial.

[crescentmotor]

Just as we think Anavex is starting to execute, today's PR is a reminder of how poorly the company handles its PR.

AVXL's communications efforts have a compelling history of missteps and I have criticized the company for years in this area. One thing the Street abhors and punished stock prices for is uncertainty. When shorts control your company's stock price and are short 25% of the float, the company has to issue clear and succinct PRs to avoid giving the shorts ammunition. AVXL today effectively turned a stand up triple into a foul ball. This is a misstep 100% on them.

How did such a clinical success story "drug effective beyond 4 years" turn into a "Now we need a phase 3 trial but we don't have a phase 3 plan yet" in front of the 500 CEOs.

No one on this board, including The Shade Thrower--Investor2014, has a clue as to what today's confusing disclosure really means. Elon Musk would be at loss to accurately interpret the meeting. What is becoming a lot clearer, after the recent stock price drop of 19%, is that the JPM conference may well turn out to be a non-event in terms of a meaningful positive impact on AVXL's stock price. Shame on AVXL for this sloppiness.

[hnbadger1]

100% agree with this post! I’ve been heavily invested here for 10 years now and have always supported Missling. But , when I read the PR this morning, I instantly knew what the reaction would be! Of all the positive quotes to put in a very important PR, why put a confusing quote that could be potentially disastrous if another P3 is required.
Frankly, I’m a little pizt at the company at the moment. This was supposed to be a great “coming out week” for the company, but instead we are down another 10 percent, partially because of a poorly worded PR!